^
    1m
    CART-PSMA Cells for Advanced Prostate Cancer (clinicaltrials.gov)
    P1, N=20, Recruiting, Nova Therapeutics LLC | Trial primary completion date: Dec 2024 --> Dec 2025
    Trial primary completion date • Metastases
    |
    FOLH1 expression
    |
    cyclophosphamide • CART-PSMA
    2years
    CART-PSMA Cells for Advanced Prostate Cancer (clinicaltrials.gov)
    P1, N=20, Recruiting, Nova Therapeutics LLC
    New P1 trial • Metastases
    |
    IFNG (Interferon, gamma) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL2 (Interleukin 2) • IL10 (Interleukin 10)
    |
    FOLH1 expression
    |
    cyclophosphamide • CART-PSMA